Lyell Immunopharma Stock Technical Analysis
| LYEL Stock | USD 16.93 0.48 2.76% |
As of the 15th of November 2025, Lyell Immunopharma secures the Risk Adjusted Performance of 0.1241, mean deviation of 3.02, and Downside Deviation of 3.7. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lyell Immunopharma, as well as the relationship between them. Please verify Lyell Immunopharma variance, as well as the relationship between the value at risk and skewness to decide if Lyell Immunopharma is priced some-what accurately, providing market reflects its recent price of 16.93 per share. Given that Lyell Immunopharma has jensen alpha of 0.6673, we recommend you to check Lyell Immunopharma's last-minute market performance to make sure the company can sustain itself at a future point.
Lyell Immunopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Lyell, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to LyellLyell Immunopharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Lyell Immunopharma Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 14.0 | Hold | 4 | Odds |
Most Lyell analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Lyell stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Lyell Immunopharma, talking to its executives and customers, or listening to Lyell conference calls.
Lyell Immunopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Lyell Immunopharma Technical Analysis
Indicator |
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of Lyell Immunopharma volatility developed by Welles Wilder.
Lyell Immunopharma Trend Analysis
Use this graph to draw trend lines for Lyell Immunopharma. You can use it to identify possible trend reversals for Lyell Immunopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Lyell Immunopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Lyell Immunopharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Lyell Immunopharma applied against its price change over selected period. The best fit line has a slop of 0.13 , which means Lyell Immunopharma will continue generating value for investors. It has 122 observation points and a regression sum of squares at 608.56, which is the sum of squared deviations for the predicted Lyell Immunopharma price change compared to its average price change.About Lyell Immunopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Lyell Immunopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Lyell Immunopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Lyell Immunopharma price pattern first instead of the macroeconomic environment surrounding Lyell Immunopharma. By analyzing Lyell Immunopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Lyell Immunopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Lyell Immunopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | PB Ratio | 20.58 | 14.87 | 8.74 | 8.31 | Capex To Depreciation | 1.35 | 0.13 | 0.0236 | 0.0225 |
Lyell Immunopharma November 15, 2025 Technical Indicators
Most technical analysis of Lyell help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lyell from various momentum indicators to cycle indicators. When you analyze Lyell charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1241 | |||
| Market Risk Adjusted Performance | 0.4996 | |||
| Mean Deviation | 3.02 | |||
| Semi Deviation | 3.13 | |||
| Downside Deviation | 3.7 | |||
| Coefficient Of Variation | 559.05 | |||
| Standard Deviation | 4.36 | |||
| Variance | 19.05 | |||
| Information Ratio | 0.1615 | |||
| Jensen Alpha | 0.6673 | |||
| Total Risk Alpha | 0.327 | |||
| Sortino Ratio | 0.1905 | |||
| Treynor Ratio | 0.4896 | |||
| Maximum Drawdown | 29.19 | |||
| Value At Risk | (4.47) | |||
| Potential Upside | 8.48 | |||
| Downside Variance | 13.7 | |||
| Semi Variance | 9.8 | |||
| Expected Short fall | (3.48) | |||
| Skewness | 0.7378 | |||
| Kurtosis | 3.23 |
Lyell Immunopharma November 15, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Lyell stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 941.14 | ||
| Daily Balance Of Power | (0.53) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 17.23 | ||
| Day Typical Price | 17.13 | ||
| Price Action Indicator | (0.54) |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyell Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in banks. For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyell Immunopharma. If investors know Lyell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyell Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (22.75) | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets | Return On Equity |
The market value of Lyell Immunopharma is measured differently than its book value, which is the value of Lyell that is recorded on the company's balance sheet. Investors also form their own opinion of Lyell Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Lyell Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyell Immunopharma's market value can be influenced by many factors that don't directly affect Lyell Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyell Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyell Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyell Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.